Sengenics believes that forging strong external alliances is an essential part of our strategy to access great science. Sengenics is pursuing potential collaborators for early stage opportunities in order to identify and develop innovative products in the following areas of interest:
The KREX™ Technology Accesss Programme (iTAP) is primarily targeted at pharmaceutical and biotechnology companies to rapidly enhance and grow their biomarker, drug and diagnostic discovery portfolios in a deep collaborative fashion by fully leveraging Sengenics’ Immunome protein array technology.
We’d love to hear more about your work and perspective. Let’s start a conversation by filling up the form below: